Back
Perspective Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
30
CATX
Perspective Therapeutics
Last Price:
9.88
Seasonality Move:
3.69%
7 Day Trial
ALL ACCESS PASS
$
7
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion Superproject- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.38 | Sell |
| 20-day SMA: | 12.03 | Sell |
| 50-day SMA: | 14.61 | Sell |
| 200-day SMA: | 8.17 | Buy |
| 8-day EMA: | 10.47 | Sell |
| 20-day EMA: | 11.89 | Sell |
| 50-day EMA: | 13.1 | Sell |
| 200-day EMA: | 9.9 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.38 | Sell |
| Relative Strength Index (14 RSI): | 33.33 | Sell |
| Chaikin Money Flow: | 1638221 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.78 - 14.58) | Sell |
| Bollinger Bands (100): | (9.9 - 15.82) | Sell |
Perspective Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 9.51 while CATX 8-day simple moving average is 10.38, which is a Sell signal.
- The stock price of CATX is 9.51 while Perspective Therapeutics 20-day SMA is 12.03, which makes it a Sell.
- Perspective Therapeutics 50-day simple moving average is 14.61 while CATX share price is 9.51, making it a Sell technically.
- CATX stock price is 9.51 and Perspective Therapeutics 200-day simple moving average is 8.17, creating a Buy signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Sell
The current Perspective Therapeutics [CATX] share price is $9.51. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
641.11M
Price in USD:
9.51
Share Volume:
1.99M
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.05
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 9.51 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 9.51 while CATX 8-day exponential moving average is 10.47, which is a Sell signal.
- The stock price of CATX is 9.51 while Perspective Therapeutics 20-day EMA is 11.89, which makes it a Sell.
- Perspective Therapeutics 50-day exponential moving average is 13.10 while CATX share price is 9.51, making it a Sell technically.
- CATX stock price is 9.51 and Perspective Therapeutics 200-day simple moving average is 9.90, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is -1.38, suggesting Perspective Therapeutics is a Sell
- Perspective Therapeutics Relative Strength Index (RSI) is 33.33, which suggest Perspective Therapeutics is oversold
- The Bollinger Bands (25) for Perspective Therapeutics is (10.78 - 14.58), which suggest Perspective Therapeutics is a Sell
- The Bollinger Bands (100) for Perspective Therapeutics is (9.9 - 15.82), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.